Top Penny Stock Signal: CTXR
Report Date: 06-25-2022
Symbol: CTXR - Citius Pharmaceuticals, Inc.
Sector:
Industry:
Top Penny Stock Signal: CTXR
Citius Pharmaceuticals, Inc. (CTXR)
11 Commerce Dr Fl 1
Cranford, NEW JERSEY 07016
Phone: 19089676677
Website: http://www.citiuspharma.com
CEO: Mr. Myron Holubiak
NASDAQ, Nasdaq Capital Market
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.